Loading clinical trials...
Loading clinical trials...
An exploratory Phase 2, single, centre, prospective, randomized, placebo-controlled, double-blinded, split-pace (left/right) design trial to evaluate the efficacy and tolerability of LEO 43204 in adul...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
LEO Pharma
NCT07205107 · Acne Vulgaris
NCT06225570 · Acne Vulgaris
NCT05891795 · Acne Vulgaris
NCT06447480 · Acne Vulgaris
NCT06141330 · Acne Vulgaris
Torrance Clinical Research Institute Inc.
Lomita, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions